PubMed · 1996 · 20 citations · 32 references
MedicineMolecular GeneticsOncologyCarcinogenesisNeoplasiaOncogenesCancer Molecular PathologyMalignant NeoplasmsPancreatic CancerPancreatic PathologyRas Family OncogenesTumor HistopathologyKras Mutation AnalysisP53 AbnormalityP53 InactivationP53 MutationP53 Pathway Inactivation
K-ras and p53 gene alterations are frequently found in human pancreatic carcinomas and cell lines. The aim of this study was to analyze for the presence of K-ras and p53 gene mutations in hamster pancreatic tumors and cell lines. Mutations at the first coding exon of the K-ras gene and in exons V to VIII of the hamster p53 gene were analyzed in six cell lines (H2T, PC1, PC1.2, PC1.0, WD, and PD) and in N-nitroso-bis(2-oxopropyl)amine-induced pancreatic (n = 9) and extra-pancreatic (n = 4) tumors. K-ras mutations were present in seven of the nine pancreatic tumors and in all extra-pancreatic tumors. No p53 mutations were detected in the tumors. All cell lines analyzed contained K-ras mutations. Moreover, four of the six cell lines contained single amino acid substitutions in the p53 gene. Cell lines derived from nitrosamine-induced pancreatic tumors in the hamster contained K-ras and p53 alterations similar to those found in cell lines derived from human pancreatic carcinomas.
32
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Concepción Almoguera, Darryl Shibata, Kathleen Forrester et al. · Cell · 1988 · 2.1K citations
Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE.
Bruce Budowle, Ranajit Chakraborty, A M Giusti et al. · PubMed · 1991 · 920 citations
Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis
Miguel Quintanilla, Ken Brown, Martin Ramsden et al. · Nature · 1986 · 865 citations